{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Ffindmyvaccine.simplecast.com%2Fepisodes%2Fcichighlights-nLBZTr7z","width":444,"version":"1.0","type":"rich","title":"Highlights from CIC 2023","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/017450d4-6458-4a10-9297-ca289770dc2d/6e937dd1-b39b-4bdf-8dbe-b69d0514f3be/copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-copy-of-aqua-and-yellow-gi-2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/3a499ea6-9bf3-4f82-8fa9-d5ca3dbd82ec\" height=\"200\" width=\"100%\" title=\"Highlights from CIC 2023\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"🎙️🎙️🎙️ ️ 𝐁𝐢𝐠 𝐍𝐞𝐰𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐡𝐞𝐚𝐫𝐭 𝐨𝐟 𝐂𝐚𝐧𝐚𝐝𝐚'𝐬 𝐜𝐚𝐩𝐢𝐭𝐚𝐥! 🍁\n\n 𝐖𝐞'𝐫𝐞 𝐭𝐡𝐫𝐢𝐥𝐥𝐞𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐭𝐡𝐚𝐭 𝐰𝐞'𝐫𝐞 𝐥𝐚𝐮𝐧𝐜𝐡𝐢𝐧𝐠 𝐚 𝐩𝐨𝐝𝐜𝐚𝐬𝐭 𝐬𝐞𝐫𝐢𝐞𝐬 𝐬𝐭𝐫𝐚𝐢𝐠𝐡𝐭 𝐟𝐫𝐨𝐦 𝐎𝐭𝐭𝐚𝐰𝐚, 𝐛𝐫𝐨𝐚𝐝𝐜𝐚𝐬𝐭𝐢𝐧𝐠 𝐚𝐥𝐥 𝐭𝐡𝐞 𝐚𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐂𝐈𝐂 𝟐𝟎𝟐𝟑.\n\n𝐓𝐡𝐢𝐬 𝐞𝐩𝐢𝐬𝐨𝐝𝐞 𝐢𝐬 𝐲𝐨𝐮𝐫 𝐚𝐥𝐥-𝐚𝐜𝐜𝐞𝐬𝐬 𝐩𝐚𝐬𝐬 𝐭𝐨 𝐚 𝐜𝐮𝐫𝐚𝐭𝐞𝐝 𝐬𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝟑 𝐬𝐡𝐨𝐫𝐭 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧𝐬 𝐰𝐢𝐭𝐡 𝐜𝐥𝐢𝐧𝐢𝐜𝐢𝐚𝐧 𝐭𝐡𝐨𝐮𝐠𝐡𝐭 𝐥𝐞𝐚𝐝𝐞𝐫𝐬  𝐚𝐧𝐝 𝐠𝐚𝐦𝐞 𝐜𝐡𝐚𝐧𝐠𝐞𝐫𝐬 𝐰𝐡𝐨 𝐚𝐫𝐞 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐩𝐮𝐛𝐥𝐢𝐜 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐛𝐞𝐲𝐨𝐧𝐝.\n\n𝙏𝙪𝙣𝙚 𝙞𝙣, 𝙩𝙪𝙧𝙣 𝙪𝙥 𝙩𝙝𝙚 𝙫𝙤𝙡𝙪𝙢𝙚, 𝙖𝙣𝙙 𝙩𝙧𝙖𝙣𝙨𝙛𝙤𝙧𝙢 𝙩𝙤𝙜𝙚𝙩𝙝𝙚𝙧. 🎧 #𝘾𝙄𝘾2023 #𝙋𝙤𝙙𝙘𝙖𝙨𝙩 #𝙊𝙩𝙩𝙖𝙬𝙖\n\n\n🎙️🎙️🎙️ MINI EPISODE 1: A Conversation with Dr.Sonia Anand MD, PhD, FRCPC\n💡 💡 💡Ensuring immunization of structurally disadvantaged populations: Black People and other people of colour\n\nPodcast Learning objectives\n • Describe how race-disaggregated data can allow for more targeted, community-specific interventions. \n• Apply novel community-specific work to engage communities to support immunization. \n• Illustrate how anti-Black racism presents a pervasive barrier to engaging with preventive health care initiatives.\n\nFor this mini podcast, we delve into how historical and systemic racism creates hurdles not only in understanding vaccine coverage discrepancies in Canada, but also in crafting effective, nuanced responses. We spotlight the distinctive obstacles Black and Asian communities in Canada have faced in accessing vaccines, both amidst the pandemic and prior to it. In the absence of detailed race-specific data for monitoring diseases preventable by vaccines and tracking vaccination rates, it is difficult to adequately cater to marginalized communities who face systemic barriers to healthcare access, including vaccinations. Dr.Anand unpacks this complex issue.\n\nAbout Dr.Sonia Anand MD, PhD, FRCPC\nProfessor of Medicine and Epidemiology, McMaster\nSenior Scientist Population Health Research Institute\nTier 1 Canada Research Chair in Ethnic Diversity and Cardiovascular Disease\nHeart and Stroke Chair in Population Health\nAssociate Chair of Equity and Diversity, Department of Medicine\nDirector of Chanchlani Research Centre\n\nDr. Sonia Anand is a professor in the Department of Medicine, and the Director of the Population Genomics Program, at McMaster. She is also a senior scientist at the Population Health Research Institute at Hamilton Health Sciences. Dr. Anand holds a Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, and the Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research. In 2010, Dr. Anand was named among the top 100 women by the Women’s Executive Network for her accomplishments in research and medicine. Her current research focuses on environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease.\n\n🎙️🎙️🎙️ MINI EPISODE 2: A Conversation with  Dr.Wayne Ghesquiere MD, FRCPC \n💡 💡 💡Long-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: Interim efficacy, immunogenicity and safety results at approximately 10 years after initial vaccination \n\nPodcast Learning objectives \n\n•\tDiscuss the interim efficacy of the adjuvanted recombinant zoster vaccine approximately 10 years post-vaccination.\n•\tExplain the immunogenicity of the adjuvanted recombinant zoster vaccine and how it contributes to its long-term protection against herpes zoster.\n•\tEvaluate the safety profile of the adjuvanted recombinant zoster vaccine based on data collected over approximately 10 years.\n•\tAnalyze the significance of these interim results in the context of long-term vaccine strategies against herpes zoster.\n•\tIncorporate the provided insights into clinical practice and future research regarding herpes zoster vaccination strategies.\n•\tCommunicate effectively to patients about the long-term benefits and safety of the adjuvanted recombinant zoster vaccine\n\n\nAbout Dr.Wayne Esquire MD, FRCPC\n\nDr Wayne Ghesquiere is a Clinical Infectious Diseases, Tropical Diseases and Internal Medicine consultant in Victoria BC as well as the former section chief for infectious diseases with the Vancouver Island Health Authority, VIHA.  \nWayne is a Clinical Assistant Professor of Medicine with University of British Columbia. Teaches internal medicine residents and infectious diseases fellows. He is an attending physician at the Royal Jubilee and the Victoria General Hospitals in Victoria, BC. He has an inpatient and a private outpatient practice in infectious diseases.\nWayne is the chair and organizer of the annual Infectious Diseases Update in Victoria now in it’s 26th year. He is also the medical director of the Nova Travel Medicine and Immunization Clinic in Victoria.\nCurrent areas of interests include clinical research in Hepatitis B and C antiviral therapies, new vaccines, and teaching. He is a principal investigator of many clinical trials. He has publications in peer-reviewed medical journals including the NEJM, Lancet, Clinical Infectious Diseases, CMAJ, Open Medicine and others.\n\n\n🎙️🎙️🎙️ MINI EPISODE 3: A Conversation  with Dr. Juthaporn Cowan, MD, FRCPC\n💡 💡 💡Management of COVID-19 in immunocompromised patients: Are you up to date?\n\nThis podcast episode is centered around COVID-19 protection strategies for immunocompromised patients. Additionally, listeners will gain up to date insight into the range of tools available for these patients' protection and treatment, including antivirals and both active and passive vaccination methods. We'll also tackle ongoing concerns regarding the management of COVID-19 amidst the persistent emergence of new variants, emphasizing the necessity of regular revisits and modifications to these management strategies.\n\nPodcast Learning Objectives \n• Describe the medical challenges faced by immunocompromised patients and discuss the unmet need for additional protection against SARS – CoV-2.\n • Address the most recent data for prevention and treatment of COVID-19 in immunocompromised patients including the use of monoclonal antibodies. \n• Share best practices for the optimum clinical management of COVID-19 in immunocompromised patients in the current Canadian context.\n\nAbout Dr. Juthaporn Cowan, MD, FRCPC\nAssistant Professor, Associate Scientist, The Ottawa Hospital Research Institute \n\nDr.Juthaporn Cowan is an Associate Scientist at The Ottawa Hospital Research Institute, Assistant Professor at The University of Ottawa, cross-appointed Assistant Professor at the Department of Biochemistry, Microbiology and Immunology and a Physician for the Division of Infectious Diseases at The Ottawa Hospital.\n\nDr. Cowan began her training at Mahidol University in Thailand for her MD. She also obtained a PhD in Microbiology and Immunology at Kyoto University in Kyoto, Japan. She completed a Postdoctoral Fellowship at The Ottawa Hospital Research Institute. Her research at the time focused on Tuberculosis and immunopathogenesis. She then started her Internal Medicine training at the University of Ottawa. During her postgraduate training her interest shifted from tuberculosis to infection in immunodeficiency patients. Subsequently, she completed a Clinical Fellowship in Infectious Diseases with the University of Ottawa.\n\nDrs.D.William Cameron and Cowan run an immunodeficiency/immunoglobulin treatment clinic in Ottawa\n\n"}